Identification of a novel role of ZMIZ2 protein in regulating the activity of the Wnt/β-catenin signaling pathway

Journal of Biological Chemistry

Volumn 288, Issue 50, 2013, Pages 35913-35924

  Lee, Suk Hyung ^a   Zhu, Chunfang ^a   Peng, Yue ^a   Johnson, Daniel T ^a   Lehmann, Lynn ^a   Sun, Zijie ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CO-IMMUNOPRECIPITATIONS; CONDITIONED MEDIUM; EXPRESSION VECTORS; MOUSE EMBRYONIC FIBROBLASTS; PROTEIN INHIBITORS; PROTEIN-PROTEIN INTERACTIONS; TRANSCRIPTIONAL CO-ACTIVATORS; WNT SIGNALING PATHWAYS;

CELL CULTURE; LIGANDS; MAMMALS; PIGMENTS; PROTEINS;

TRANSCRIPTION;

BETA CATENIN; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN ZMIZ2; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

Β-CATENIN; CELL SIGNALING; PIAS-LIKE PROTEINS; PROTEIN-PROTEIN INTERACTIONS; TRANSCRIPTION REGULATION; WNT LIGAND; WNT SIGNALING; ZMIZ2;

ANIMALS; ANTIGENS, CD44; AXIN PROTEIN; BETA CATENIN; CELL LINE; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; WNT PROTEINS;

EID: 84890421419     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.529727     Document Type: Article

References (61)

1. Shuai, K. (2000) Modulation of STAT signaling by STAT-interacting proteins. Oncogene 19, 2638-2644
2. Megidish, T., Xu, J. H., and Xu, C. W. (2002) Activation of p53 by protein inhibitor of activated Stat1 (PIAS1). J. Biol. Chem. 277, 8255-8259
3. Jackson, P. K. (2001) A new RING for SUMO. Wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev. 15, 3053-3058
4. Kotaja, N., Karvonen, U., Jänne, O. A., and Palvimo, J. J. (2002) PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell Biol. 22, 5222-5234
5. Schmidt, D., and Müller, S. (2003) PIAS/SUMO. New partners in transcriptional regulation. Cell Mol. Life Sci. 60, 2561-2574
6. Wu, L., Wu, H., Ma, L., Sangiorgi, F., Wu, N., Bell, J. R., Lyons, G. E., and Maxson, R. (1997) Miz1, a novel zinc finger transcription factor that interacts with Msx2 and enhances its affinity for DNA. Mech. Dev. 65, 3-17
7. Nishida, T., and Yasuda, H. (2002) PIAS1 and PIASxα function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. J. Biol. Chem. 277, 41311-41317
8. Kahyo, T., Nishida, T., and Yasuda, H. (2001) Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell 8, 713-718
9. Huang, C. Y., Beliakoff, J., Li, X., Lee, J., Li, X., Sharma, M., Lim, B., and Sun, Z. (2005) hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated transcription and interacts with SWI/SNF-like BAF complexes. Mol. Endocrinol. 19, 2915-2929
10. Sharma, M., Li, X., Wag, Y., Zarnegar, M., Huang, C. Y., Palvimo, J. J., Lim, B., and Sun, Z. (2003) hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci. EMBO J. 22, 6101-6114
11. Gutiérrez, L., Zurita, M., Kennison, J. A., and Vázquez, M. (2003) The Drosophila trithorax group gene tonalli (tna) interacts genetically with the Brahma remodeling complex and encodes an SP-RING finger protein. Development 130, 343-354
12. Beliakoff, J., and Sun, Z. (2006) Zimp7 and Zimp10, two novel PIAS-like proteins, function as androgen receptor coregulators. Nucl. Recept. Signal 4, e017
13. Li, X., Thyssen, G., Beliakoff, J., and Sun, Z. (2006) The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity. J. Biol. Chem. 281, 23748-23756
14. Lee, J., Beliakoff, J., and Sun, Z. (2007) The novel PIAS-like protein hZmip10 is a transcriptional co-activator of the p53 tumor suppressor. Nucleic Acids Res. 35, 4523-4534
15. Li, X., Zhu, C., Tu, W. H., Yang, N., Qin, H., and Sun, Z. (2011) ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract. PLoS ONE 6, e25040
16. Peng, Y., Lee, J., Zhu, C., and Sun, Z. (2010) A novel role for protein inhibitor of activated STAT (PIAS) proteins in modulating the activity of Zimp7, a novel PIAS-like protein, in androgen receptor-mediated transcription. J. Biol. Chem. 285, 11465-11475
17. Soler, G., Radford-Weiss, I., Ben-Abdelali, R., Mahlaoui, N., Ponceau, J. F., Macintyre, E. A., Vekemans, M., Bernard, O. A., and Romana, S. P. (2008) Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation. Leukemia 22, 1278-1280
18. Rogers, L. M., Riordan, J. D., Swick, B. L., Meyerholz, D. K., and Dupuy, A. J. (2013) Ectopic expression of Zmiz1 induces cutaneous squamous cell malignancies in a mouse model of cancer. J. Invest. Dermatol. 133, 1863-1869
19. Rakowski, L. A., Garagiola, D. D., Li, C. M., Decker, M., Caruso, S., Jones, M., Kuick, R., Cierpicki, T., Maillard, I., and Chiang, M. Y. (2013) Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias. Cancer Res. 73, 930-941
20. Beliakoff, J., Lee, J., Ueno, H., Aiyer, A., Weissman, I. L., Barsh, G. S., Cardiff, R. D., and Sun, Z. (2008) The PIAS-like protein Zimp10 is essential for embryonic viability and proper vascular development. Mol. Cell Biol. 28, 282-292
21. Nusse, R. (2003) Wnts and Hedgehogs. Lipid-modified proteins and similarities in signaling mechanisms at the cell surface. Development 130, 5297-5305
22. Nusse, R. (2005) Wnt signaling in disease and in development. Cell Res. 15, 28-32
23. Amit, S., Hatzubai, A., Birman, Y., Andersen, J. S., Ben-Shushan, E., Mann, M., Ben-Neriah, Y., and Alkalay, I. (2002) Axin-mediated CKI phosphorylation of β-catenin at Ser-45. a molecular switch for the Wnt pathway. Genes Dev. 16, 1066-1076
24. Hart, M. J., de los Santos, R., Albert, I. N., Rubinfeld, B., and Polakis, P. (1998) Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3 β. Curr. Biol. 8, 573-581
25. Latres, E., Chiaur, D. S., and Pagano, M. (1999) The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-catenin. Oncogene 18, 849-854
26. Aberle, H., Bauer, A., Stappert, J., Kispert, A., and Kemler, R. (1997) β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797-3804
27. Polakis, P. (1999) The oncogenic activation of β-catenin. Curr. Opin. Genet. Dev. 9, 15-21
28. Eastman, Q., and Grosschedl, R. (1999) Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr. Opin. Cell Biol. 11, 233-240
29. Mazieres, J., He, B., You, L., Xu, Z., and Jablons, D. M. (2005) Wnt signaling in lung cancer. Cancer Lett. 222, 1-10
30. Neth, P., Ries, C., Karow, M., Egea, V., Ilmer, M., and Jochum, M. (2007) The Wnt signal transduction pathway in stem cells and cancer cells. Influence on cellular invasion. Stem Cell Rev. 3, 18-29
31. Yang, F., Li, X., Sharma, M., Sasaki, C. Y., Longo, D. L., Lim, B., and Sun, Z. (2002) Linking β-catenin to androgen-signaling pathway. J. Biol. Chem. 277, 11336-11344
32. Thyssen, G., Li, T. H., Lehmann, L., Zhuo, M., Sharma, M., and Sun, Z. (2006) LZTS2 is a novel β-catenin-interacting protein and regulates the nuclear export of β-catenin. Mol. Cell Biol. 26, 8857-8867
33. Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., and Naldini, L. (1998) A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-8471
34. Farson, D., Witt, R., McGuinness, R., Dull, T., Kelly, M., Song, J., Radeke, R., Bukovsky, A., Consiglio, A., and Naldini, L. (2001) A new-generation stable inducible packaging cell line for lentiviral vectors. Hum. Gene Ther. 12, 981-997
35. Luo, J., Deng, Z. L., Luo, X., Tang, N., Song, W. X., Chen, J., Sharff, K. A., Luu, H. H., Haydon, R. C., Kinzler, K. W., Vogelstein, B., and He, T. C. (2007)Aprotocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat. Protoc. 2, 1236-1247
36. Verras, M., Brown, J., Li, X., Nusse, R., and Sun, Z. (2004) Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells. Cancer Res. 64, 8860-8866
37. Sun, Z., Yergeau, D. A., Tuypens, T., Tavernier, J., Paul, C. C., Baumann, M. A., Tenen, D. G., and Ackerman, S. J. (1995) Identification and characterization of a functional promoter region in the human eosinophil IL-5 receptor α subunit gene. J. Biol. Chem. 270, 1462-1471
38. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔ C(T)) method. Methods 25, 402-408
39. Sharma, M., Zarnegar, M., Li, X., Lim, B., and Sun, Z. (2000) Androgen receptor interacts with a novel MYST protein, HBO1. J. Biol. Chem. 275, 35200-35208
40. Leung, J. Y., Kolligs, F. T., Wu, R., Zhai, Y., Kuick, R., Hanash, S., Cho, K. R., and Fearon, E. R. (2002) Activation of AXIN2 expression by β-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J. Biol. Chem. 277, 21657-21665
41. Jho, E. H., Zhang, T., Domon, C., Joo, C. K., Freund, J. N., and Costantini, F. (2002) Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell Biol. 22, 1172-1183
42. Bates, G. J., Nicol, S. M., Wilson, B. J., Jacobs, A. M., Bourdon, J. C., Wardrop, J., Gregory, D. J., Lane, D. P., Perkins, N. D., and Fuller-Pace, F. V. (2005) The DEAD box protein p68. A novel transcriptional coactivator of the p53 tumour suppressor. EMBO J. 24, 543-553
43. Peng, Y., Clark, C., Luong, R., Tu, W. H., Lee, J., Johnson, D. T., Das, A., Carroll, T. J., and Sun, Z. (2011) The leucine zipper putative tumor suppressor 2 protein LZTS2 regulates kidney development. J. Biol. Chem. 286, 40331-40342
44. Tetsu, O., and McCormick, F. (1999) β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426
45. Polakis, P. (2000) Wnt signaling and cancer. Genes Dev. 14, 1837-1851
46. Lustig, B., Jerchow, B., Sachs, M., Weiler, S., Pietsch, T., Karsten, U., van de Wetering, M., Clevers, H., Schlag, P. M., Birchmeier, W., and Behrens, J. (2002) Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell Biol. 22, 1184-1193
47. Rodriguez-Magadán, H., Merino, E., Schnabel, D., Ramírez, L., and Lomelí, H. (2008) Spatial and temporal expression of Zimp7 and Zimp10 PIAS-like proteins in the developing mouse embryo. Gene Expr. Patterns 8, 206-213
48. Rodríguez-Magadán, H., Ramírez, L., Schnabel, D., Vázquez, M., and Lomelí, H. (2010) Sexually dimorphic gene expression of the Zimp7 and Zimp10 genes in embryonic gonads. Gene Expr. Patterns 10, 16-23
49. Haegel, H., Larue, L., Ohsugi, M., Fedorov, L., Herrenknecht, K., and Kemler, R. (1995) Lack of β-catenin affects mouse development at gastrulation. Development 121, 3529-3537
50. Grigoryan, T., Wend, P., Klaus, A., and Birchmeier, W. (2008) Deciphering the function of canonical Wnt signals in development and disease. Conditional loss- and gain-of-function mutations of β-catenin in mice. Genes Dev. 22, 2308-2341
51. -/- colon carcinoma. Science 275, 1784-1787
52. Voeller, H. J., Truica, C. I., and Gelmann, E. P. (1998) β-Catenin mutations in human prostate cancer. Cancer Res. 58, 2520-2523
53. Chesire, D. R., Ewing, C. M., Sauvageot, J., Bova, G. S., and Isaacs, W. B. (2000) Detection and analysis of β-catenin mutations in prostate cancer. Prostate 45, 323-334
54. Gerstein, A. V., Almeida, T. A., Zhao, G., Chess, E., Shih Ie, M., Buhler, K., Pienta, K., Rubin, M. A., Vessella, R., and Papadopoulos, N. (2002) APC/ CTNNB1 (β-catenin) pathway alterations in human prostate cancers. Genes Chromosomes Cancer 34, 9-16
55. Chen, G., Shukeir, N., Potti, A., Sircar, K., Aprikian, A., Goltzman, D., and Rabbani, S. A. (2004) Up-regulation of Wnt-1 and β-catenin production in patients with advanced metastatic prostate carcinoma. Potential pathogenetic and prognostic implications. Cancer 101, 1345-1356
56. Chesire, D. R., Ewing, C. M., Gage, W. R., and Isaacs, W. B. (2002) In vitro evidence for complex modes of nuclear β-catenin signaling during prostate growth and tumorigenesis. Oncogene 21, 2679-2694
57. de la Taille, A., Rubin, M. A., Chen, M. W., Vacherot, F., de Medina, S. G., Burchardt, M., Buttyan, R., and Chopin, D. (2003) β-Catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells. Clin. Cancer Res. 9, 1801-1807
58. Graham, T. A., Weaver, C., Mao, F., Kimelman, D., and Xu, W. (2000) Crystal structure of a β-catenin/Tcf complex. Cell 103, 885-896
59. Huber, A. H., Nelson, W. J., and Weis, W. I. (1997) Three-dimensional structure of the armadillo repeat region of β-catenin. Cell 90, 871-882
60. Hurlstone, A., and Clevers, H. (2002) T-cell factors. Turn-ons and turnoffs. EMBO J. 21, 2303-2311
61. Daniels, D. L., and Weis, W. I. (2002) ICAT inhibits β-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules. Mol. Cell 10, 573-584